arrow_back Back to App

Designating July 17, 2024, as Glioblastoma Awareness Day

The U.S. Senate designates July 17, 2024, as Glioblastoma Awareness Day to raise public awareness about this aggressive and deadly brain tumor. The resolution honors patients and caregivers, and strongly encourages continued investment in research and collaborative efforts to develop better treatments. This aims to improve the long-term prognosis and quality of life for those diagnosed with glioblastoma, a disease associated with high out-of-pocket medical costs.
Key points
July 17, 2024, is officially designated as Glioblastoma Awareness Day to boost public understanding of the disease and its urgent medical needs.
The resolution calls for increased funding and collaboration in research to find new treatments, recognizing the high mortality rate and complexity of GBM.
Support is expressed for patients, families, and caregivers who face significant challenges and high out-of-pocket medical costs.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 118_SRES_735
Sponsor: Sen. Graham, Lindsey [R-SC]
Process start date: 2024-06-13
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating July 17, 2024, as "Glioblastoma Awareness Day".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_SRES_735.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2024-06-13.

What are the main provisions?

Key points include:

  • July 17, 2024, is officially designated as Glioblastoma Awareness Day to boost public understanding of the disease and its urgent medical needs.
  • The resolution calls for increased funding and collaboration in research to find new treatments, recognizing the high mortality rate and complexity of GBM.
  • Support is expressed for patients, families, and caregivers who face significant challenges and high out-of-pocket medical costs.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Graham, Lindsey [R-SC].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S4096; text: CR S4090)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health